Status Epilepticus Clinical Trials

16 recruiting

Status Epilepticus Trials at a Glance

24 actively recruiting trials for status epilepticus are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Sohag, San Francisco, and Columbus. Lead sponsors running status epilepticus studies include Sohag University, University of California, San Francisco, and Xuanwu Hospital, Beijing.

Browse status epilepticus trials by phase

Treatments under study

About Status Epilepticus Clinical Trials

Looking for clinical trials for Status Epilepticus? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Status Epilepticus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Status Epilepticus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Phase 3

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Status Epilepticus
University of Virginia770 enrolled51 locationsNCT06907173
Recruiting
Not Applicable

Improving Status Epilepticus Treatment Times

Status Epilepticus
Nationwide Children's Hospital450 enrolled1 locationNCT06194747
Recruiting
Not Applicable

KD Treatment for Super-refractory Status Epilepticus

Super-refractory Status Epilepticus
Xuanwu Hospital, Beijing84 enrolled15 locationsNCT07496749
Recruiting

Augmented Renal Clearance in Neurocritical Care

Ischemic StrokeIntracerebral HemorrhageTBI (Traumatic Brain Injury)+4 more
University of Alberta512 enrolled3 locationsNCT07410624
Recruiting
Phase 2Phase 3

Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)

Convulsive Status EPILEPTICUS
Sohag University668 enrolled1 locationNCT07095842
Recruiting

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Cardiac ArrestStatus Epilepticus
University of Milano Bicocca80 enrolled10 locationsNCT05756621
Recruiting
Not Applicable

Simulation Trial of Telemedical Support for Paramedics

Acute Respiratory FailureEmergenciesCardiopulmonary Arrest+1 more
Boston Medical Center420 enrolled4 locationsNCT06441760
Recruiting
Phase 2Phase 3

Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children

Generalized Convulsive Status Epilepticus
Sohag University124 enrolled1 locationNCT07046611
Recruiting
Phase 2

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

SeizuresStatus EpilepticusHeart Arrest
University of California, San Francisco52 enrolled1 locationNCT06401707
Recruiting

De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information

EpilepsySeizuresStatus Epilepticus
University of New Mexico20,000 enrolled1 locationNCT05140265
Recruiting
Phase 2

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

SeizuresStatus EpilepticusHypoxia-Ischemia, Brain+4 more
University of California, San Francisco30 enrolled1 locationNCT05851391
Recruiting
Not Applicable

EEG Monitoring for Refractory Status Epilepticus

Status Epilepticus
Barts & The London NHS Trust40 enrolled1 locationNCT04170491
Recruiting
Not Applicable

Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis

Status EpilepticusDysimmune Encephalopathy
Assistance Publique - Hôpitaux de Paris400 enrolled1 locationNCT04421846
Recruiting

Study of Patients with Electrical Status Epilepticus in Sleep

Electrical Status Epilepticus in Sleep
East Suffolk and North Essex NHS Foundation Trust20 enrolled1 locationNCT06792396
Recruiting
Not Applicable

The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus

Status EpilepticusIctal-interictal Continuum
Universitaire Ziekenhuizen KU Leuven200 enrolled1 locationNCT06017973
Recruiting
Phase 3

Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)

Non-Convulsive Status Epilepticus
University of Southern Denmark140 enrolled4 locationsNCT05263674
Recruiting
Phase 2Phase 3

Exogenous Ketone Esters for Refractory Status Epileptics

Status Epilepticus
Sohag University50 enrolled1 locationNCT05674552
Recruiting

The STatus Epilepticus Prognosis Study

Status Epilepticus
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's50 enrolled1 locationNCT06590883
Recruiting

Rapid-Response EEG in Children With Suspected Status Epilepticus

Status Epilepticus
Children's Hospital at Montefiore60 enrolled1 locationNCT06564662
Recruiting
Not Applicable

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

Refractory Status Epilepticus
Xuanwu Hospital, Beijing32 enrolled1 locationNCT06344338